Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Aim: The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces
the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 …

A COMPLETE UPDATE AND REVISION OF THE CLASSIC TEXT" At last, a manual of
operations for comparing the cost-effectiveness of a preventive service with a treatment …

Objectives: We studied the prognostic implications of midwall fibrosis in dilated
cardiomyopathy (DCM) in a prospective longitudinal study. Background: Risk stratification of …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

ContextLeft ventricular (LV) systolic dysfunction causes substantial morbidity and mortality,
even with optimal pharmacotherapy. Atrial-synchronized biventricular pacemakers (cardiac …

Downloaded from scores the need for risk stratification techniques to identify patients at high
risk for these events and effective interventions that can prevent or abort these events …

Health care spending has risen steadily in most countries, becoming a concern for decision-
makers worldwide. Commentators often point to new medical technology as the key driver …

Background—We hypothesized that combined assessment of factors that are associated
with favorable reverse remodeling after cardiac resynchronization-defibrillator therapy (CRT …

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society
Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk …